What is the recommendation for patients with a history of ischemic stroke, atrial fibrillation, and coronary artery disease?
For patients with a history of ischemic stroke, atrial fibrillation, and coronary artery disease, the usefulness of adding antiplatelet therapy to oral anticoagulants is uncertain for purposes of reducing the risk of ischemic cardiovascular and cerebrovascular events. Unstable angina and coronary artery stenting represent special circumstances in which management may warrant dual antiplatelet/oral anticoagulation. The recommendation for this population is rated as IIb C-LD, meaning the recommendation is reworded for clarity from the 2014 Secondary Prevention and the Cor is unchanged.